Citius Oncology (CTOR) vs Equillium (EQ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Equillium (EQ) has outperformed Citius Oncology (CTOR) over the past year, losing 6.7% versus a loss of 54.7%. Equillium is the larger company by market cap ($91.3 million vs $88.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | EQ |
|---|---|---|
| Share price | $0.835 | $1.44 |
| Market cap | $88.31M | $91.31M |
| 1-day change | -2.45% | +3.60% |
| YTD return | -14.90% | -10.32% |
| 1-year return | -54.73% | -6.71% |
| 5-year return | — | -76.48% |
| EPS (TTM) | $-0.48 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $3.54 |
| 52-week low | $0.491 | $0.76 |
| Distance from 52-week high | -62.89% | -59.32% |
| Average volume | 99.72K | 614.50K |
| Shares outstanding | 105.76M | 63.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EQ has outperformed CTOR by 48.0 percentage points over the past year.
CTOR vs EQ FAQ
Which is bigger, Citius Oncology or Equillium?
Equillium (EQ) is larger, with a market capitalization of $91.31M compared with $88.31M for Citius Oncology (CTOR).
Which stock has performed better over the past year, CTOR or EQ?
EQ returned -6.71% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Equillium in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.